English

BioStock: How Magle Group focus their use of DSM

Report this content

The company aims to establish itself as a leader in life-changing healthcare innovations. Watch Justin Pierce, CEO and Helena Ossmer Thedius, Chief Marketing and Innovation Officer, explain their technology platform of degradable starch microspheres (DSM), serving as the base for development of new products, in BioStock Studio.

Watch the interview at biostock.se/en/:

https://www.biostock.se/?p=52215&preview=true

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Subscribe

Documents & Links

Quick facts

BioStock: How Magle Group focus their use of DSM
Tweet this